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Advances in optical coherence tomography
in dermatology—a review
Jonas Olsen,a,* Jon Holmes,b and Gregor B. E. Jemeca
aUniversity of Copenhagen, Zealand University Hospital, Department of Dermatology, Health Sciences Faculty, Roskilde, Denmark
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Abstract. Optical coherence tomography (OCT) was introduced as an imaging system, but like ultrasonogra-
phy, other measures, such as blood perfusion and polarization of light, have enabled the technology to approach
clinical utility. This review aims at providing an overview of the advances in clinical research based on the
improving technical aspects. OCT provides cross-sectional and en face images down to skin depths of 0.4
to 2.00 mm with optical resolution of 3 to 15 μm. Dynamic optical coherence tomography (D-OCT) enables
the visualization of cutaneous microvasculature via detection of rapid changes in the interferometric signal
of blood flow. Nonmelanoma skin cancer (NMSC) is the most comprehensively investigated topic, resulting
in improved descriptions of morphological features and diagnostic criteria. A refined scoring system for diag-
nosing NMSC, taking findings from conventional and D-OCT into account, is warranted. OCT diagnosis of mela-
noma is hampered by the resolution and the optical properties of melanin. D-OCT may be of value in diseases
characterized with dynamic changes in the vasculature of the skin and the addition of functional measures is
strongly encouraged. In conclusion, OCT in dermatology is still an emerging technology that has great potential
for improving further in the future. © 2018 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.23.4.040901]
Keywords: optical coherence tomography; interferometry; medicine; dermatology; imaging.
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1 Introduction
Imaging may seem superfluous in the skin as most of it is easily
visible to the naked eye. Nevertheless, recording of images
through technology may contribute significantly to our ability
both to see the actual structures of the skin and visualize
their functioning. Imaging therefore has a long tradition within
dermatology, originating in drawings that convey the artist’s
impression of skin changes either clinically or as drawings of
histopathology.
Simple imaging has traditionally been done using a magni-
fying lens, and more recently, the use of the dermoscope has
penetrated into routine clinical work. This simple operator-
dependent technique involves the use of a magnifying lens with
a contact-pane obliterating surface reflections. It is particularly
well suited for diagnosis of pigmented lesions and provides
important morphological insights into a range of other skin
pathologies.
More detailed imaging can, however, also be done in vivo
using reflectance confocal microscopy (RCM), optical coher-
ence tomography (OCT), and ultrasonography. These methods
are at various stages of implementation into clinical routine.
Additional methods, e.g., photoacoustic imaging, are available
in an experimental setting.
It is customary for imaging methods to start off as pure
imaging, but the competitive advantage of a traditional holistic
clinical approach has meant that the penetration of new imaging
methods into routine clinical assessment of the skin is still low.
Simple clinical photography and dermoscopy show the highest
penetration into clinical work, as these methods are entirely
operator dependent and only act as adjunct clinical examina-
tions. By contrast, e.g., magnetic resonance imaging has become
widely used, not least due to the method’s possibility to furnish
the clinicians with objective and functional data about the tissue
under study. A similar evolution may be taking place in derma-
tology. The older imaging technology of high frequency ultra-
sound has gained considerable penetration into specialties, such
as gynecology, in recent years. It may be speculated that this is
due to the method’s ability to provide functional data on the
tissue. This is also possible in skin1 and in spite of the limited
resolution of the images provided, ultrasound is increasingly
popular.
The use of OCT in skin appears to be following a similar
path. It started out as a pure imaging system, providing clini-
cians with micrometer resolution images of skin. These images
were more accurate than existing ultrasonography, and less so
than, e.g., RCM. In spite of the fact that greater volumes of skin
could be imaged than in RCM, the overall image quality of OCT
did not compare favorably with that of RCM.Measures to weigh
up for the small field-of-view in RCM have been made by ena-
bling the acquisition of several scans in a larger field of up to
8 mm × 8 mm. On the other hand, the introduction of more
functional measures, such as perfusion, in OCT means that the
method is now approaching clinical utility much more rapidly.
It is highly suited for this as the images clearly provide more
detail than simple magnifying glasses while, at the same time,
promising to show functional aspects of the skin.
2 Technology and Technological Advances
2.1 Summary of Optical Coherence Tomography
OCT is a technique for imaging turbid media, such as living
tissue, and was applied to imaging skin in 1997 by Welzel et al.2
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As an imaging modality, it occupies a space between acoustic
imaging and confocal microscopy in terms of its resolution and
imaging depth, typically imaging to a depth of 0.4 to 2.00 mm
with optical resolution of 3 to 15 μm. OCT utilizes the property
of coherence of laser light to detect scattered light from target
tissue at depths, which are inaccessible to conventional micros-
copy. A focused laser beam is scanned across the sample, and
backscattered light from the subsurface tissue is collected and
made to interfere with a reference beam also derived from the
laser. Only backscattered photons that have retained their coher-
ence by not being multiply scattered within the tissue will con-
structively interfere and generate a large signal response at the
detector. Furthermore, the interferometer provides the depth
information at which these photons were backscattered, thus
enabling a 2-D image of the scattering centers within the tissue
to be constructed.
2.2 Optical Coherence Tomography Imaging of Skin
Skin, as a particularly easy organ to access, was one of the first
parts of the body to be scanned with OCT. It was quickly dis-
covered by early researchers that it was necessary to use the
1300-nm waveband in the water absorption spectral window to
obtain satisfactory image depth penetration in skin. Normal skin
comprises an epidermis of 50 to 100 μm above a dermis of up to
2000 μm or more thickness. For clinically useful OCT images, it
is important for imaging to penetrate at least 500 μm into the
dermis and, unfortunately, the visible wavelengths commonly
applied in ophthalmic imaging are scattered too highly by skin
to achieve acceptable depth penetration. Other wavelengths
have been studied, notably 1050 nm,3 but all commercial skin
imaging OCT devices use the 1300-nm waveband (see Fig. 1 for
examples of OCT scans from currently available commercial
devices).
2.3 Advances in Optical Coherence Tomography
Technology
The driver for advances in OCT technology for imaging skin
has been a clinical interest in imaging skin cancer, in particular,
nonmelanoma skin cancer (NMSC). This disease manifests as
the tumor “nests” initially in the upper 500 μm, which grow
and penetrate to 1000 μm and deeper. There are numerous
other features that can be mistaken for tumors in OCT images,
such as hair follicles, cysts, and benign growths, and so, high
image resolution to successfully distinguish between these over
the full imaging depth of 1000 μm is desired. Initial studies
using time-domain OCT systems quickly established that
probes providing lateral resolution of 15 to 25 μm provided
images of insufficient detail to achieve really useful sensitivity
and specificity for NMSC diagnosis; for example, in 2007,
Mogensen et al.4 reported diagnostic sensitivity of 50% to
96% and specificity of 79% to 94% in a study of 100 patients.
Nevertheless, these studies showed that clinically useful image
features were being glimpsed and further improvements in
resolution would likely yield useful results, encouraging
further development of higher resolution probes with resolution
<10 μm.
The early studies with utilizing time-domain OCT high-
lighted another challenge in terms of the scan rate. Skin lesions
can be quite large −1 cm diameter is not uncommon—and early
systems with an imaging time of 1 to 2 s per OCT image frame
were too slow to be practical for routine clinical use.
The first commercially available device was the ISIS
Optronics SkinDex, and this had a 2-s frame capture time for
a 1-mm width image frame. The impressively high optical res-
olution of ∼3 μm of this device was unfortunately compromised
by the slow scan rate and unwieldy probe, and it was not clin-
ically adopted.
However, the development of Fourier-domain OCT5 coupled
with rapid advances in computer processing power enabled real-
time scan rates, and then by the addition of a second scan mirror,
i.e., the rapid capture of three-dimensional datasets. In 2010,
Michelson Diagnostics launched VivoSight, the first practical
commercial dermatology OCT system that has been adopted
into routine clinical practice. This device combined a swept-
source Fourier-domain OCT engine with multibeam optical
configuration, combining four OCT devices each focused at a
different depth into one probe, to achieve lateral resolution of
7.5 μm over a full desired focal depth of 1000 μm and 3-D
scanned area of 6 mm × 6 mm.6 The fiber-based hand-held
probe was small enough to easily manipulate and scan most
parts of the face and body. These practical advances in image
resolution, scan rate, and probe ergonomics encouraged clinical
studies and then adoption into routine practice.7 In 2014,
the utility of the VivoSight probe was further improved with
the addition of a color microcamera providing the user with the
facility to see the lesion being scanned and the exact location of
the scan plane on the lesion.
In 2010, Agfa launched the SkinTell® (Agfa, Mortsel,
Belgium) dermatological OCT system with so-called high-def-
inition OCT (HD-OCT). This device addressed the image res-
olution problem by using time-domain OCTengine with en-face
OCT imaging mode, high NA objective lens, and tracking the
focus during the scan. The resolution of 3 μm of HD-OCT was
higher than VivoSight but at the expense of a less ergonomic
probe, lower scan area of 1.8 mm × 1.5 mm, and image penetra-
tion of 570 μm. Clinical studies with this device showed
Fig. 1 Examples of normal skin from three different OCT devices. (a) Vivosight® (Michelson Diagnostics
Ltd., Maidstone, United Kingdom), (b) Callisto® (Thorlabs AG, Lubeck, Germany), and (c) NITID®
(DermaLumics, Madrid, Spain).
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promising results,8 but the device was withdrawn from the mar-
ket by the manufacturer at the end of 2015.
More recently, in 2015, Dermalumics launched the NITID
OCT device. This very compact and highly portable dermato-
logical OCT system has a probe equipped with dermatoscope
and clinical camera so that all three imaging modalities are avail-
able to the clinical user. Its image resolution is 12 μm9 and,
currently, clinical studies using the device are lacking.
2.4 Advances in Optical Coherence Tomography
Modalities
Besides the key advances in image resolution, scan rate, depth
penetration, and probe ergonomics, advances have also been
made in the functional OCT imaging of skin. These include
polarization-sensitive OCT and angiographic or “dynamic
OCT (D-OCT).”
An important constituent of skin tissue is collagen, which is
highly birefringent. The collagen fibers themselves are very
small and difficult to resolve optically unless very high NA
optics is used. Polarization-sensitive OCT has been studied for
possible use in managing burns,10 because heat denatures the
collagen and destroys its birefringence. A difficulty is that the
images are quite difficult to interpret visually, and the higher
cost of polarization-maintaining optical components is also
problematic preventing the development of a practical PS-
OCT device.
Early developments of OCT included studies of Doppler
OCT to detect blood flow.11 The limited sensitivity of these
devices stifled application in dermatology, but since 2015, there
has been great interest in angiographic OCT based on so-called
speckle-variance techniques pioneered by Mariampillai et al.12
Speckle variance and its close cousins decorrelation mapping13
and OMAG14 work on the principle of detecting rapid changes
in OCT signal intensity that are produced by the effects of
blood flow producing changes to the OCT interferometric
signal; by mapping the image pixels where these rapid changes
are detected, blood vessels in the upper dermis can be readily
imaged and are best visualized in the en-face imaging plane
(see Figs. 2–5).
D-OCT has already been studied for potential applications
in skin cancer diagnosis, scleroderma, psoriasis, wound
healing, and many other areas, and it shows promise for the
future.
3 Applications in Dermatology
The clinical applicability of OCT is high in ophthalmology,
where OCT is routinely used and considered a key tool in diag-
nosing various diseases of the retina.15 In dermatology, OCT
studies on various skin diseases have been conducted, though
the technology has yet to be implemented as a standard pro-
cedure in clinical practice. In this section, we focus on compar-
ing studies conducted from 2015 to 2017 with former studies to
bring forth an overview of the advances in clinical research. One
obvious limitation for imaging depth in OCT and other laser-
based imaging technologies is the optical properties of chromo-
phores in human tissue. Molecules, such as melanin and water,
Fig. 2 Healthy skin of the back of the hand from a 59-year-old man. (a) 6 × 2 mm cross-sectional OCT-
scan showing a narrow bright band, i.e., the entry signal, a homogenous narrow epidermis, an intact DEJ
and a brighter and more heterogeneous dermis. (b) 6 × 6 mm en face D-OCT image at 300 μm showing
a high degree of dots and small caliber serpiginous vessels in a mottle-pattern and regular distribution.
The research project for which the OCT images were initially acquired was approved by the local ethics
committee, project id: SJ-509.
Fig. 3 AK in the right temporal of a 68-year-old woman. (a) 6 × 2 mm cross-sectional OCT-scan showing
thickening of the epidermis with a disrupted DEJ and a poor penetration depth beneath. (b) 6 × 6 mm
en face D-OCT image at 300 μm showing a moderate degree of curves and serpiginous vessels with
alternating calibers and branching pattern in an irregular distribution.
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have an effect on the OCT-image quality due to the absorption of
light at wavelengths used in OCT, increasing the amount of light
absorption and scattering and therefore reducing the imaging
depth in tissue rich on said molecules.16
3.1 Skin Cancer
3.1.1 Nonmelanoma skin cancer
As a disease originating from the epidermis and the most
prevalent type of skin cancer,17 NMSC is the most studied
field of research in OCT.18–40 In recent years, studies on NMSC
have focused on diagnostic accuracy;41–43 scoring systems
or algorithms for diagnosing and differentiating basal cell
carcinoma (BCC) and actinic keratosis (AK);44–48 treatment
monitoring49–51 and D-OCT morphology of NMSC.52,53 Earlier
studies on NMSC have also been aimed at determining diagnos-
tic accuracy38 and applied OCT as a treatment monitoring
tool,18,21,22,37,40 though D-OCT had yet to be introduced.
Validation of any emerging imaging technique is the corre-
lation with existing methods and since the first pilot study in
2004, a series of studies have shown good morphological cor-
relation between OCT and histology in BCC.23,26,29–32 The most
distinct features in B-scans were used in creating the Berlin
score in an attempt to set a range of objective criteria and to
quantify the diagnostic accuracy using these criteria48 (see sec-
tion below regarding diagnostic algorithms). Tumor thickness in
BCC is another interesting feature, which has been studied with
OCT and correlated with histology. Studies have shown that
OCT has a good correlation with histology in determining
epidermal thickness (ET).36 The method is superior to high fre-
quency ultrasonography, showing better agreement with histol-
ogy, though both methods overestimated thickness.35 Another
study found a median insignificant difference of 0.12 mm
between histology and OCT compared to a significant median
difference of 0.3 mm between histology and ultrasonography.34
AK has not been studied as comprehensively, leaving only a
single pilot study comparing OCT and histology, also showing
a good correlation.20
The diagnostic accuracy in NMSC has been studied on cross-
sectional OCT images only, without any clinical information.
An overall sensitivity of 76% and 90% and specificity of
68% and 90% for AK and BCC, respectively, among observers
experienced in OCT image interpretation was found.41 A former
study on observer blinded diagnostic accuracy in distinguishing
NMSC and malignant melanoma from healthy skin has shown
a sensitivity and specificity of 79% to 94% and 85% to 96%,
respectively, whereas the error rate in discriminating between
AK and BCC was only 50% to 52%.38 In newer studies of
OCT as a supplement to clinical assessment of BCC, one study
has shown OCT to improve the sensitivity in diagnosing BCC
from 90% to 95.7% and specificity from 28.6% to 75.3%,
the latter showing statistical significance (p < 0.001)42 while
another study has shown a significant improvement in both sen-
sitivity and specificity (p < 0.01) from 63% to 93% and 49% to
80%, respectively, when applying OCT as a supplement to
clinical diagnostics.43 Polarization-sensitive OCT (PS-OCT) has
been used in a pilot study for identifying tumor margins in
aggressive BCC, showing a loss of birefringence in tumor
islands and a shift to a more uniform birefringence in unaffected
Fig. 5 Malignant melanoma on the left forearm of a 48-year-old woman. (a) 6 × 2 mm cross-sectional
OCT-scan showing thickening and increased signal intensity in the epidermis, disruption of the DEJ and
a steep fall in signal intensity in the dermis. (b) 6 × 6 mm en faceD-OCT image at 300 μm showing a high
degree of curves and dots and a moderate degree of lines in a mottled pattern with an irregular
distribution.
Fig. 4 BCC from the right temple of an 84-year-old woman. (a) 6 × 2 mm cross-sectional OCT-scan
showing thickening of the epidermis with ovoid structures with dark palisading border underneath pro-
truding into the dermis and with a disruption of the DEJ. (b) 6 × 6 mm en face D-OCT image at 300 μm
showing serpiginous, curved and dilated telangiectasias and vessels in an arborizing pattern.
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skin. This method was, however, unable to identify the deeper
tumor margins.33 A recent study from 2016 investigated the
automated detection of BCC with PS-OCT in ex vivo human
skin using machine learning algorithms. They achieved 95.4%
sensitivity and specificity.54 A former murine study with similar
methods shows the usability of PS-OCT in automated tumor
detection. They found a sensitivity and specificity of 94.4%
and 92.5%, respectively, when taking both signal intensity
and birefringence into account compared to 78.2% and 82.2%
when only looking at intensity and 85.5% and 87.9% with
birefringence alone.24
The use of OCT in presurgical tumor margin assessment
of NMSC has been tested in a practical approach, conducting
the scans perpendicular to the clinically assessed tumor margins.
The OCT-defined margins always fell within the clinically
assessed borders and correctly indicated complete removal
of tumor tissue in 84% of cases. Lateral margin definition
before Mohs micrographic surgery of BCC has been investi-
gated in a recent study from 2018, showing a reduction in
the number of surgical stages during Mohs surgery. The method
enabled the complete removal of tumor tissue in a single stage in
8/10 cases, and tumor margins were enlarged after OCT in 4/10
cases.55
Diagnostic algorithms for BCC and AK have been suggested
and validated in recent years. For BCC, the Berlin score has
been developed using an expert panel and afterward applied
for these criteria: dark border underneath tumor, hyporeflective
nests, ovoid structures, disruption of the dermoepidermal junc-
tion (DEJ) and cysts, resulting in a sensitivity and specificity
among experts 96.6% and 75.2%, respectively.48 Another algo-
rithm for discriminating BCC subtypes and imitators using HD-
OCT has developed, suggesting the presence of lobular structure
as a hallmark for BCC and other features, such as connection
to hair follicles and nests in the epidermis, may imply BCC
imitators while the subtyping of BCC is based on vascular
patterns.45 An algorithm for differentiating AK, squamous cell
carcinoma (SCC), and normal skin using HD-OCT has also
been developed and validated, suggesting the presence of an
outlined DEJ in cross-sections to be the main discriminator
between SCC and AK or normal skin and the presence of an
atypical honey comb pattern (en face) and alternating hyperkera-
tosis/parakeratosis (cross-section) to be an identifier for AK in
discriminating it from normal skin.44,47 The validation of this
algorithm resulted in a sensitivity of 81.6% and 93.8% and
specificity of 92.6% and 98.9% in diagnosing AK and SCC,
respectively, among experienced observers.47
Changes in quantitative measures such as attenuation
and signal intensity in NMSC have been investigated in few
studies. A study on the signal intensity and attenuation of
BCC has shown significant differences in signal density and
attenuation between BCC and healthy skin,56 whereas another
study found that distinction between AK and BCC can be made
on a drop in signal intensity in the dermis and a thicker epi-
dermis for AK.57 A study in HD-OCT demonstrated that sub-
differentiation of BCC can be made with a higher accuracy
when applying optical properties compared to morphology
analysis alone.58
The monitoring of therapeutic response to treatment is
another field of OCT research that has developed recently.
A higher accuracy of identifying residual BCC lesions and
confirmation of complete response after photodynamic therapy
compared to clinical evaluation has been shown in Ref. 51.
This correlates well with former studies performed suggesting
that OCT is able to identify residual lesions after treatment with
a higher precision than clinical examination alone.18,59 A study
on the effect of systemic hedgehog inhibitors on BCCmonitored
with RCM and HD-OCT has revealed that pseudocysts may
be a marker of tumor regression, though the small sample
size of five patients suggests the study and the phenomenon
comprehensively.37
D-OCT enables the study of in vivo blood flow and has been
clinically validated against other vascular imaging techniques
and is able to image and identify physiological changes in
the blood flow of the skin60 as well as morphological changes
in vessel morphology.61 The microvascular structural morphol-
ogy of AK, Bowen’s disease, and SCC was studied with D-OCT
applying an observer blinded analysis. Several morphological
characteristics of blood vessels have been identified and the
presence of “blobs” at 300 μm was characteristic in Bowen’s
disease and “curves” were present in AK lesions, though no sig-
nificant difference was found in quantitative measures between
precancer and cancer lesions.52 Examples of D-OCT images of
NMSC and the nomenclature for describing the vessels in the
horizontal en face images and morphology of the cross-sectional
images are shown in Figs. 2–5. The depth of blood vessels in
various types of NMSC was studied, showing significantly more
superficial vessels in AK, BCC, and SCC, respectively, com-
pared to healthy skin but also in BCC compared to AK and
SCC.53
As a natural field of interest, the first pilot study on OCT of
melanocytic lesions was published in 2005. There was a low
degree of correlation between OCT and histological features,
and it was not possible to visualize individual cells. It was con-
cluded that the technology was still far from the possibility of
being brought into practical use in the dermatological oncology
sector.62 The distinction between malignant melanoma and
melanocytic naevi is of the highest relevance in the field of
dermatology, and though OCT may be somewhat limited in
diagnosing pigmented lesions due to light scattering and absorp-
tion of the melanin16 and less resolution than RCM, the technol-
ogy may have its uses in tumor thickness estimation. Like in
BCC, a study has shown that OCT has a higher degree of agree-
ment with histology in determining tumor thickness in melano-
cytic lesions.63 On the other hand, the wavelength of the OCT-
device influences the penetration depth, and studies have shown
that high frequency ultrasound is superior to OCT-scans at
930 nm in determining tumor thickness.64 A recent study has
shown OCTat 1300 nm to be slightly more accurate in assessing
tumor thickness, though both technologies tend to overestimate
thin tumors (<0.2 mm) and underestimate thick tumors
(>0.7 mm) compared to histology.65 In a descriptive study
using HD-OCT in pigmented lesions, melanomas have, com-
pared to benign lesions, a higher frequency of fusion of rete
ridge, pagetoid cells, and junctional and/or dermal nests with
atypical cells. HD-OCT is suggested to have a higher diagnostic
value in pigmented lesions compared to conventional OCT
while being inferior to RCM.66 Older studies suggest a higher
degree of architectural disarray and fused and elongated rete
ridges and to be a marker of malignancy in pigmented lesions,67
and HD-OCT is able to visualize similar features as RCM with
a good correlation with histological findings.68 A multicenter
study of HD-OCT in the differentiation of cutaneous melanoma
and melanocytic naevi with 66 naevi and 27 melanoma
patients has demonstrated a sensitivity of 74.1%, specificity
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of 92.4%, positive predictive value of 80%, and negative
predictive value of 89.7% in diagnosing melanoma.69 Another
HD-OCT-study of pigmented lesions has suggested the possibil-
ity to raise sensitivity and specificity to 93.3% and 93.7%,
respectively, while taking optical properties such as attenuation
into account.70
3.2 Other Applications
3.2.1 Inflammatory diseases
The introduction of D-OCT to dermatological research has
meant an obvious improvement compared to earlier studies in
the ability to evaluate the microvascular morphology of inflam-
matory skin. The earliest OCT study on inflammatory skin dis-
eases is a descriptive study of dermatitis and psoriasis from
2003. The study describes a thickening of the epidermis in pso-
riasis and irritant dermatitis, and the light scattering ability of the
dermis was lower than regular skin due to less tightly packed
collagen fibers in the edematous and inflamed dermis.71 In
recent years, a range of inflammatory skin disorders, including
acne, dermatitis, and nail psoriasis, has been studied with
OCT.72–74 D-OCT of acne vulgaris has revealed characteristic
morphological features including interrupted entrance signal,
increased ET, vertical hypodense structures, and granular
hyper echogenic material inside comedos. The vascular charac-
teristics include focal absence of vascular signals, hypervascular
spikes, and increased vascular networks. The study has also
shown a correlation between oral antibiotic treatment and nor-
malization of the above mentioned features.72 Differentiation of
allergic and irritant dermatitis in patch test scoring has been
assessed with HD-OCT and a good correlation between certain
features in HD-OCT and clinical severity scores was shown,
though no significant improvement over visual patch test scor-
ing could be demonstrated.73 Allergic patch test scoring was also
evaluated with OCT in a pilot study from 2005, showing clearly
demarcated signal-free cavities within the epidermis. This find-
ing correlated well with the grading of the clinical patch test
scoring.75 OCT has also been applied as an assessment tool
of outcomes in clinical trials for dermatitis and psoriasis. The
atrophogenic potential of hydrocortisone 1% and pimecrolimus
in the skin of patients with atopic dermatitis was investigated in
which dermal thickness and ET were evaluated using OCT.
It was demonstrated that hydrocortisone but not pimecrolimus
induced a significant decrease in ET, which normalized
4 weeks past ended treatment.76 Almost the same study design
was applied in a study of plaque psoriasis comparing tacrolimus
and methylprednisolone aceponate ointment, in which OCT and
ultrasonography were applied for confirming the clinically
scored outcomes.77 The disease severity in psoriasis has been
evaluated with histology and psoriasis area and severity index
(PASI) score and ET being evaluated by OCT. The ET showed
a good correlation with histology rated disease severity but not
with the PASI score.78 A study of nail psoriasis has shown a
significantly increased blood flow and greater nail thickness
in the proximal nail fold, and morphological features of psoriatic
nail blood vessels differed from controls with dilated and
disorganized blood vessels in the superficial proximal nail
fold.74 A systematic approach in studying inflammatory skin
diseases with OCT has been suggested prior to the introduction
of D-OCT by Boone et al.79 for HD-OCT, suggesting a termi-
nology resembling that of RCM.
3.2.2 Physiological studies
OCT has been applied as an assistance for planning and control-
ling various treatments, such as follicular unit extraction, laser-
assisted drug delivery through nails and skin, and for semiauto-
mated localization of the DEJ.80–86 OCT is able to visualize the
nail plate, nail bed, and nail matrix,87 and the method has been
using for assessing effectiveness of transnail drug delivery using
ablative fractional laser with OCT, suggesting the technology to
be an effective tool for monitoring both depth of laser penetra-
tion and drug delivery efficacy in nails.80,81 Measurement of nail
thickness with OCT has been applied, showing lower degrees of
variation compared to ultrasonography,87 though lacking the
ability to visualize single cellular structures compared to confo-
cal laser scanning microscopy.88 A “demonstration of principle”
study to assist the planning of follicular unit extraction with
OCT has been made in order to easily evaluate the angles of
hair follicles during hair transplants. This evaluation was per-
formed in order to minimize hair follicle transection and the
authors suggest that the principle may be applied for automa-
tized follicle unit extraction devices.83 The epidermis is the easi-
est part of the skin to visualize with OCT and several studies on
the ET were conducted.89–95 Different methods for measuring
ET with OCT were tested using A-scan based analysis, shape-
let-based analysis, and manual observer-based analysis, the lat-
ter two being most precise.93 A-scan analysis with histological
comparison has revealed no correlation between methods,
suggesting the method to be unviable in determining ET.89,91
Even though a recent study on a software-based semiautomated
method for assessing the ET using A-scan data has shown
a strong correlation with histology and manual assessment,
a poor numerical agreement was found. This suggests that
different methods may not be used interchangeably.95 Manual
measurement of ET on B-scans OCT has been shown to be
reproducible with a low degree of variation and has been
used in determining variations due to age and gender, skin
type, and anatomical location.90,92 Atrophic thinning of the
epidermis is a common side effect of glucocorticosteroids, and
OCT has been used for the evaluation of ET in a double-blind
placebo controlled trial on healthy volunteers, showing OCT to
be superior to ultrasound in detecting early signs of epidermal
thinning.96 Hair straws are known to cause artifacts in OCT
scans due to their light scattering ability, and this can be
exploited in examining hair thickness with B-scans, providing
highly reproducible in vivo measurements of hair shaft thick-
ness, whereas other methods are more time-consuming and
requiring removal of hairs.97 When evaluating hair removal,
OCT is able to provide cross-sectional views of the hair
shaft and follicle, whereas other methods only provide images
en face.98
3.2.3 Other diseases
OCT has been used in the investigation of various diseases of
interest in dermatology. Vascular diseases of the skin have been
investigated prior to the introduction of D-OCT. Blood vessels
were identified vessels as hyporeflective structures in the reticu-
lar dermis of hemangiomas, hemolymphangiomas, and telan-
giectasia, showing good correlation with histology.99,100
Burns and scars after burns were studied with OCT. The
assessment of vasculature is an important aspect of monitoring
healing of burn injuries, and with the introduction of D-OCT,
it is possible to track the vascular progression during wound
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healing.101 The treatment planning of laser therapy to burn scars
is normally based on the physician’s estimate on thickness of the
scar tissue, and therefore, OCT has been employed for setting a
more standardized and precise estimate of the scar thickness,
revealing physicians to underestimate the scar thickness in
the dermis.102 Deep and superficial burns have been compared
with PS-OCT, in which both vasculature and connective tissue
birefringence of the reticular dermis were diminished in the deep
burns.10 Blood vessels in hypertrophic burn scar tissue have a
higher density compared to normal skin with proliferation of
larger vessels compared to both normal skin and regular scar
tissue, which found in an OCT study using speckle decorrelation
to delineate blood vessels.103
The bullous diseases: pemphigus, bullous pemphigoid, burn
blisters, subcorneal pustular dermatosis, Dariers disease, staphy-
lococcal scalded skin syndrome (SSSS), and toxic epidermal
necrolysis (TEN) have been studied while depicting bullae as
dark ovoid well-demarcated structures in the epidermis.104,105
OCT is able to differentiate bullous pemphigoid from burn blis-
ters and pemphigus due to the different levels of epidermal split-
ting but lacks the ability to assess tissue damage in the dermis in
burns.105 The same phenomenon can be observed in differenti-
ating SSSS and TEN, where a SSSS demonstrates a split higher
in the epidermis, and TEN shows a split at the DEJ.104 Parasitic
infestations of the skin with scabies mites and larva migrans and
the naturally occurring demodex mites have been demonstrated
with OCT.106–108 Both larva migrans and scabies mites created
subcorneal burrows, though only the scabies mite was visualized
with OCT.106,107 Demodex mites are situated corresponding to
hair follicles and their degree of presence can be demonstrated
with HD-OCT enabling treatment monitoring in demodex-
related diseases.108 As mentioned earlier, the nail plate,
nail fold, and nail matrix are visualizable with OCT, and various
nail involving diseases have been investigated with OCT.109–111
Onychomycosis can be seen as highly scattering elongated
structures in the nail plate,110 though showing a high rate of
false positives compared to polymerase chain reaction, fungal
cultures, and confocal scanning laser microscopy.109 Psoriasis
nail involvement can be visualized with OCT as light narrow
bands with shadowing underneath. The overall agreement
between clinical assessment and OCT by the authors suggests
OCT being useable in objectively assessing treatment
response.111
4 Discussion
The development of OCT in dermatology has been going on for
30 years, and during this time, several aspects of the technology
have been improved substantially. The diagnostic accuracy,
especially regarding NMSC, has reached a point in which diag-
nostic biopsies may be avoided in one out of three cases of
BCC,43 and the sensitivity has improved from 42% to 90%
in differentiating AK from BCC for skilled observers,38,41
which may be due to increased image quality as well as
improved understanding of key diagnostic features of BCC.48
The “Berlin score” for BCC showed a good diagnostic accuracy
with a sensitivity of 96.6% and specificity of 75.2% when used
by an expert group. Since this study was conducted, vascular
features in differentiating different types of NMSC with D-OCT
have been suggested,52 possibly enabling a refinement of a score
for diagnosing NMSC in future studies. Even though great
advances in terms of diagnostic accuracy and planning and mon-
itoring of various treatments are being made, the technology
remains more experimental and lacks some obvious key features
associated with other technologies, such as reflectance confocal
microscopy in the diagnosis of melanoma.112
D-OCT adds functional aspects to OCT by allowing in vivo
assessment of microvasculature and may have applications
beyond improving diagnostic accuracy in NMSC. As a part
of the acute inflammatory response, the increase in blood
flow in the most superficial vessels of the skin may be assessed
and quantified using D-OCT,61 which has already been applied
for assessing treatment response in clinical trials,49–51 and D-
OCT may prove to be a further useful monitoring tool in clinical
trials studying inflammatory and neoplastic diseases of the skin,
though a problem may arise in case of edema of the epidermis
due to water’s ability to absorb and scatter infrared light.16 The
possible addition of new functional measures of tissue compo-
sition or metabolism is to be strongly encouraged in order to
harvest the full potential of this interesting technique in derma-
tology. Even though the information gathered from the scanned
tissue has increased with the introduction of D-OCT, other
methods for gathering supplementary data have been reduced.
PS-OCT has been studied on a broad scale, adding information
about the connective tissue birefringence, though most studies
have been published more than 5 years ago.10,33,38,87,92 Though
recent studies on automated identification and classification of
BCC using a noncommercial PS-OCT setup have been con-
ducted,24,54 suggesting that the down prioritizing of PS-OCT in
commercial devices may affect the amount of research being
conducted.
In conclusion, OCT in dermatology currently remains an
emerging technology for which the potential has yet to be
described fully. With the advancement in processing speed of
computers, the decline in laser prices and the increased demand
for quick, precise, and noninvasive diagnostic tests, the technol-
ogy has a great potential for improving its obvious utility further
in the future.
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